A small controlled trial (titled “Manipulation of Visceral Sensitivity and Immune System Activation in IBS” - ClinicalTrials.gov Identifier: NCT00418340) will test the ability of therapy with beneficial bacteria (a probiotic supplement) to affect immune activation and associated visceral nerve sensitivity by addressing bacterial infection in the gut.
Is sponsored by North West London Hospitals NHS Trust
Will recruit a small number of subjects from outpatient clinics
Has set a start date of December 2007.
For details on the trial go to the ClinicalTrials.gov website, at http://www.clinicaltrials.gov/ct2/show/NCT00418340?term=IBS&rank=21